Literature DB >> 22958047

Mandibular distraction osteogenesis for neonates with Pierre Robin sequence and airway obstruction.

Roberto Cicchetti1, Piero Cascone, Elena Caresta, Paola Papoff, Silvia Miano, Carla Cerasaro, Valerio Ramieri, Fabio Midulla, Corrado Moretti.   

Abstract

Neonates with Pierre Robin Sequence (PRS) usually present with varying degrees of upper airway obstruction and difficulty feeding. Early treatment is important for such children in order to prevent impaired cognitive development resulting from hypoxemic episodes. Various procedures aimed at widening the pharyngeal space have been proposed, including prone position, tongue-lip adhesion, mandibular traction, non-invasive ventilation and palatal plates. Mandibular distraction osteogenesis (MDO) using external or internal devices has become increasingly popular as an alternative treatment option when other medical or surgical techniques do not prove to be satisfactory. This review summarizes current evidence on the effectiveness of MDO in infants with PRS. Because of a lack of studies comparing this treatment with other procedures, general recommendations cannot be drawn and treatment of infants with PRS still requires individualization.

Entities:  

Mesh:

Year:  2012        PMID: 22958047     DOI: 10.3109/14767058.2012.715011

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  3 in total

Review 1.  Sleep and respiratory outcomes in neonates with Pierre Robin sequence: a concise review.

Authors:  Christopher Kurian; Zarmina Ehsan
Journal:  Sleep Breath       Date:  2019-06-25       Impact factor: 2.816

Review 2.  Craniofacial syndromes and sleep-related breathing disorders.

Authors:  Hui-Leng Tan; Leila Kheirandish-Gozal; François Abel; David Gozal
Journal:  Sleep Med Rev       Date:  2015-06-06       Impact factor: 11.609

3.  Pierre Robin Sequence in a Child With Ectopic Kidney, Polysyndactyly, And Short Stature: A Case Report.

Authors:  Anan Abualshamat; Abdulmoein Al-Agha
Journal:  Cureus       Date:  2019-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.